Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofogliflozin with Insulin in Type 2 Diabetes
NCT02201004Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jun 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Jun 2014; status: completed.
02
Drugs
tofogliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02201004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201004.